Health, Aging & Longevity

The user's secondary interest in physical and mental health, sleep, training, and aging — framed as optimizing the person, not just the code. Parent for narrower health-adjacent concepts.

Also known as: health, longevity, aging, ageing, healthspan, preventive medicine, wellness

Documents (2)

• Living and Working in the Age of Longevity HBR.org · 2026-08-19 source ↗ Reader 🖥️
  Because people are living and staying healthy much longer, the traditional three-stage life (educate, work, retire at 60-65) and its career-ladder metaphor no longer fit, so individuals must take up deliberate personal agency to 'weave' a life across eight threads of productivity and nurture — while organizations and institutions, which still lag behind this shift, need to stop using age as a proxy for capability and instead build the trust, performance-management, and flexibility that let people work productively, and humanly, well into their 70s, 80s and beyond.
• Én enkelt behandling kan gi svært langvarig kolesterolsenkning: – Noe radikalt nytt Bård Amundsen · 2026-05-29 source ↗ Reader 🖥️
  A single infusion of an in-vivo gene-editing therapy that permanently disables the PCSK9 gene produced deep and durable (18-month) LDL-cholesterol reduction in a small first-in-human trial, suggesting that cardiovascular disease prevention may shift from lifelong daily medication toward a one-time, vaccine-like treatment.

Propositions touching this concept (2)

By publication month, oldest first (extraction month when no publication date is known).

2026-08

• explicitThe career-ladder metaphor required energy but not personal agency (you just put one hand on the next rung); a longevity-era career instead requires individuals to actively exercise personal agency, a capability most people were never required to develop under the ladder model.
  Living and Working in the Age of Longevity · p3
• explicitInstitutions (workplace law, promotion structures, sabbatical policy) have not yet been redesigned for longevity, even though they are actively being redesigned for AI and technology — individuals are already changing their behavior (working into their 60s/70s, taking sabbaticals, freelancing, taking paternity leave) faster than institutions can follow.
  Living and Working in the Age of Longevity · p8

Open gaps (2)

• incompleteA 35-patient trial with an 18-month observation window is treated as sufficient basis for headline framing ('radically new', 'a vaccine'), without discussing statistical power, control-group design (is this placebo-controlled, dose-ranging, open-label?), or how many of the 35 patients were in the highest-dose (62%-reduction) group versus lower, less dramatic doses.
  Én enkelt behandling kan gi svært langvarig kolesterolsenkning: – Noe radikalt nytt — read next: The original NEJM paper (Vafai et al., 'In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia') for trial design details, and later Phase 2/3 results from the planned ~200-patient study.
• incompleteThe article treats 'off PCSK9' and 'lower LDL' as essentially interchangeable outcomes and never addresses whether a permanent, irreversible gene edit carries different risk than the existing reversible PCSK9-inhibitor drugs it is being compared to — e.g., what happens if a patient develops an adverse reaction years later with no way to 'undo' the edit, unlike stopping a pill or antibody injection.
  Én enkelt behandling kan gi svært langvarig kolesterolsenkning: – Noe radikalt nytt — read next: Look for expert commentary (bioethics, gene-therapy safety literature) specifically on irreversibility as a distinct risk category from reversible pharmacological intervention, rather than just 'will there be side effects'.